SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NGNE

Neurogene Inc. (NASDAQ:NGNE)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$22.15-$0.78 (-3.40%)
 
Market cap
$350M
Insider Score
Health Score
Analyst consensus
Listed since
Mar 7, 2014
Market Cap$350.02M+8.4%
Revenue (ttm)$0
Net Income-$119.18M-40.0%
EPS-$5.57-25.7%
Shares Out15.80M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume178,269
Open$22.27
Previous Close$22.93
Day's Range$22.00 - $22.90
52-Week Range$15.93 - $43.66
Beta2.09
AnalystsBuy
Price Target$72.00(+225.06%)
Earnings DateMar 23, 2027

About NGNE

Neurogene Inc. is dedicated to engineering transformative genetic treatments for individuals and their families grappling with debilitating neurological conditions. Its current pipeline prominently features two key investigational therapies: NGN-401, an AAV9 gene therapy specifically targeting Rett syndrome, and NGN-101, which is being developed to address neuronal ceroid lipofuscinosis subtype 5 (Batten disease). The company's operations are based in New York, New York.

Address
535 W 24th Street, New York City, NY, 10011, US
Market Cap
350 million
Employees
131
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$1.13M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
1 Buy0 Hold0 SellAvg target $73.00 (+229.6%)

1 firm rating NGNE in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From NGNE’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-3.40%
5 Days
-7.52%
1 Month
-8.77%
6 Months
-20.06%
1 Year
+8.37%

$NGNE stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in NGNE holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by NGNE's directors and management

Net Shares Purchased by Insiders−30k−15k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

NGNE Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New NGNE patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to NGNE from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in NGNE

VTIVanguard Morningstar Total Stock Market ETF$11.31M
IWMiShares Russell 2000 ETF$9.41M
XBIState Street SPDR S&P Biotech ETF$6.28M
VXFVanguard Extended Market ETF$4.87M
IWNiShares Russell 2000 Value ETF$3.37M
IBBiShares Biotechnology ETF$2.74M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from NGNE’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
72

News check: Analyst expectations for significant upside rally combined with Q3 earnings reporting suggest constructive market positioning.

Recent Insider Activity

Buys
0
Sells
17
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

BBCVirtus Biotech Clinical Trials ETF0.64%
IBRNiShares Neuroscience and Healthcare ETF0.59%
SBIOALPS Medical Breakthroughs ETF0.31%
TMEDT. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF0.31%
BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF0.26%
HELXFranklin Genomic Advancements ETF0.16%
IWCiShares Micro-Cap ETF0.10%
PJSMPGIM Jennison Small-Mid Cap Core Equity ETF0.08%
TSEET. Rowe Price Small Cap ETF0.07%
XBIState Street SPDR S&P Biotech ETF0.07%
VFMOVanguard U.S. Momentum Factor ETF0.05%
FESMFidelity Enhanced Small Cap ETF0.04%

Weight is the stock’s share of each fund’s holdings.